It seems that SARS‐CoV‐2 entry into cells downregulates ACE265 and this contributes to COVID‐19 pathophysiology via instigation of the hyperinflammatory cytokine storm and manifestation of cardiovascular disruption,66 while maintenance of ACE2 levels could help to alleviate this. This evidence concerns the gene ACE2 and COVID-19.